Liminal Biosciences Inc (DELISTED) (LMNL:DL)
8.50
0.00 (0.00%)
USD |
NASDAQ |
Sep 26, 16:00
Liminal Biosciences Cash from Investing (TTM): 3.340M for June 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
June 30, 2023 | 3.340M |
March 31, 2023 | 3.142M |
December 31, 2022 | 2.935M |
September 30, 2022 | 5.772M |
June 30, 2022 | 119.10M |
March 31, 2022 | 136.37M |
December 31, 2021 | 136.15M |
September 30, 2021 | 133.11M |
June 30, 2021 | 19.01M |
March 31, 2021 | 1.482M |
December 31, 2020 | 1.720M |
September 30, 2020 | 29.22M |
June 30, 2020 | 29.58M |
March 31, 2020 | 28.18M |
December 31, 2019 | 27.20M |
September 30, 2019 | -3.670M |
June 30, 2019 | -4.666M |
March 31, 2019 | -4.647M |
December 31, 2018 | -4.521M |
September 30, 2018 | -5.798M |
June 30, 2018 | -5.360M |
March 31, 2018 | -5.924M |
December 31, 2017 | 0.8634M |
September 30, 2017 | 20.28M |
June 30, 2017 | 18.77M |
Date | Value |
---|---|
March 31, 2017 | 17.41M |
December 31, 2016 | 7.476M |
September 30, 2016 | -10.94M |
June 30, 2016 | -10.40M |
March 31, 2016 | -8.788M |
December 31, 2015 | -5.821M |
September 30, 2015 | -6.413M |
June 30, 2015 | -7.032M |
March 31, 2015 | -6.492M |
December 31, 2014 | -7.925M |
September 30, 2014 | -10.26M |
June 30, 2014 | -9.412M |
March 31, 2014 | -9.580M |
December 31, 2013 | -7.398M |
September 30, 2013 | -3.828M |
June 30, 2013 | -2.301M |
March 31, 2013 | -0.8696M |
December 31, 2012 | -0.7192M |
September 30, 2012 | -1.069M |
June 30, 2012 | -1.141M |
March 31, 2012 | -1.067M |
December 31, 2011 | -1.038M |
September 30, 2011 | 0.0246M |
June 30, 2011 | -0.4943M |
March 31, 2011 | -0.5945M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-4.666M
Minimum
Jun 2019
136.37M
Maximum
Mar 2022
39.29M
Average
19.01M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
Acasti Pharma Inc | -1.452M |
Aurinia Pharmaceuticals Inc | -6.706M |
Edesa Biotech Inc | 0.00 |
Lexaria Bioscience Corp | -0.1991M |
Xenon Pharmaceuticals Inc | -117.17M |